Ceragon网络 CRNT 深 沪
等待开盘 09-03 09:30:00 美东时间
1.95
-0.080
-3.94%
华盛通- 最 高1.9999
- 今 开1.98
- 成交量 41.10万股
- 最 低 1.9454
- 昨 收 2.03
- 总市值 1.73亿
- 52周最高 5.73
- 市盈率 静 7.22
- 换手率 0.46%
- 52周最低 1.82
- 委 比 -30.17%
- 总股本 8892.97万
- 历史最高 12.21
- 量 比 0.71
- 振 幅 2.68%
- 历史最低 0.88
- 每 手 1
- 风险率 0.94%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Smarter, Faster, and More Human: Cerence AI and Volkswagen Advance Partnership to Deliver Next-Gen In-Car Conversations
Volkswagen and Cerence AI have deepened their collaboration to enhance the in-car IDA assistant using Cerence Chat Pro, enabling more natural and complex conversations. Features include multi-turn dialogue and a broader knowledge base, improving user experience and delivering added value post-purchase. The upgrade is available across various Volkswagen brands, supporting intuitive interactions that feel more human-like, thus elevating the driving...
08-25 12:00
Crinetics Receives FDA Orphan Drug Designation for Atumelnant in the Treatment of Congenital Adrenal Hyperplasia (CAH)
Crinetics Pharmaceuticals announced that the FDA granted Orphan Drug Designation (ODD) for atumelnant, a novel once-daily oral ACTH receptor antagonist for treating classic congenital adrenal hyperplasia (CAH). Atumelnant is the first small molecule ACTH receptor antagonist in clinical development. The company highlighted the significant unmet need for CAH patients and aims to demonstrate the ability to restore normal adrenal androgen levels and ...
08-21 12:45
Ceragon Networks Secures $8 Million Network Modernization Project in EMEA
Ceragon Networks ( ($CRNT) ) has issued an announcement. On August 13, 2025, Ce...
08-13 20:28
Crinetics Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
Crinetics Pharmaceuticals reported Q2 2025 financial results, highlighting progress toward its acromegaly drug PALSONIFY™ with an FDA PDUFA date of Sept 25, 2025. The company advanced multiple clinical programs, including atumelnant for CAH, and presented data at major medical meetings. Cash reserves of $1.2B are expected to support operations into 2029.
08-07 20:05
Ceragon Networks shares are trading lower after the company reported worse-than-expected Q2 financial results.
Ceragon Networks shares are trading lower after the company reported worse-than...
08-06 20:42
Earnings Scheduled For August 6, 2025
Companies Reporting Before The Bell • Lineage (NASDAQ:LINE) is likely to report...
08-06 16:33
美股大行评级 | 潜在涨幅163.16%！Craig-Hallum上调DiaMedica Therapeutics目标价至11美元，维持"买入"评级
今日重点评级关注：Craig-Hallum：维持DiaMedica Therapeutics"买入"评级，目标价从8美元升至11美元；花旗：维持Cogent Biosciences"买入"评级，目标价从15美元升至22美元
07-21 09:19
Crinetics to Present New Long-Term Data Demonstrating Durable Control of Once-Daily, Oral PALSONIFY™ (Paltusotine) in Acromegaly at ENDO 2025
Data from Crinetics' clinical trials show that PALSONIFY (paltusotine), an oral treatment for acromegaly, demonstrated durable control of IGF-1 levels, reduced symptom burden, and was well-tolerated during long-term use. Results from the PATHFNDR-1 and PATHFNDR-2 open-label extensions, presented at ENDO 2025, highlight PALSONIFY's potential as a next-generation therapy for acromegaly. In PATHFNDR-1, 91% of participants transitioned to the open-...
07-13 21:45
Crinetics Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 7, 2025
<p>Cisinetics Pharmaceuticals announced it will report its second quarter 2025 financial results on August 7, 2025 after market close. The company will host a conference call at 4:30 p.m. ET to discuss the results and provide a business update. Participants can join via phone using domestic number 1 833-470-1428 or international number 1 404-975-4839 with access code 899803. The call will also be webcast live and archived on the company's website...
07-11 12:00
Mahindra Selects Cerence Audio AI to Power In-Car Voice Interaction in its Electric Origin SUVs
Mahindra introduces two new eSUVs, the BE 6 and XEV 9e, featuring Cerence Audio AI, a cutting-edge speech enhancement technology. This partnership aims to improve in-car communication, particularly in noisy environments, by leveraging Cerence Speech Signal Enhancement (SSE) for clear interactions between drivers, passengers, and the infotainment system. Mahindra's MAIA architecture, combined with Cerence's technology, offers an intelligent, conne...
07-01 12:00
